📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

NORRISTrading & Distributors

Norris Medicines Ltd — Financial Ratios & Key Metrics

₹13.35

-1.70%

P/E RatioN/AxIndustry: 35.45x

ROEN/AReturn on equity

ROCE-10.13%Return on capital

Debt/EquityN/ADebt free ✓

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

35.45x

Dividend Yield

0.00%

Market Cap

₹14.52 (Cr)

Sales Growth 5Y

-5.78%

Profit Growth 5Y

9.35%

EPS Growth 5Y

9.35%

OPM 5Y Avg

-3.20%

📉

Price Returns

1 Month

-8.10%

3 Months

-10.09%

6 Months

-21.64%

1 Year

-25.99%

52W Low

₹12

Current

₹13

52W High

₹22

13% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹14

▼ Price below SMA 50 — Bearish

SMA 200

₹16

▼ Long-term downtrend

Volume Signal

66% of avg

Below average volume — low conviction

Technical indicators are for educational purposes only. Not investment advice.

More on Norris Medicines Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Trading & Distributors Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.